← FDA Drug Approvals (Drugs@FDA)

NORLIQVA

NDA · New Drug Application · Sponsor: CMP DEV LLC · Approved 2022-02-24

Drug application

FDA Application #

NDA214439

Application type

New Drug Application

Brand name

NORLIQVA

Generic name

AMLODIPINE

Active ingredients

AMLODIPINE BESYLATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

CMP DEV LLC

Manufacturer

CMP Pharma, Inc.

First approval

2022-02-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown